FRT
36
2
NSC
47
-3
AZO
48
3
PSA
51
5
HP
36
3
NOV
52
3
NKE
28
-2
DAL
77
-3
MAS
58
2
SPG
55
9
MAT
62
2
IRM
65
2
NWSA
73
15
AES
43
5
C
50
-4
BF.B
31
2
COF
57
-2
AMGN
47
8
O
35
5
HES
62
4
FRT
36
2
NSC
47
-3
AZO
48
3
PSA
51
5
HP
36
3
NOV
52
3
NKE
28
-2
DAL
77
-3
MAS
58
2
SPG
55
9
MAT
62
2
IRM
65
2
NWSA
73
15
AES
43
5
C
50
-4
BF.B
31
2
COF
57
-2
AMGN
47
8
O
35
5
HES
62
4
Financhill
Back

Theravance Biopharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
47

TBPH
Theravance Biopharma

Last Price:
8.23
Seasonality Move:
11.3%
Sell
45

NBY
NovaBay Pharmaceuticals

Last Price:
0.78
Seasonality Move:
-8.12%
Sell
47
Theravance Biopharma (TBPH) is a Sell

Is Theravance Biopharma a Buy, Sell or Hold?

  • The current Theravance Biopharma [TBPH] share price is $8.22. The Score for TBPH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

  • The Theravance Biopharma share price today is $8.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.

TBPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 44.11 Sell
Chaikin Money Flow: -64071 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.1 - 8.64) Sell
Bollinger Bands (100): (7.9 - 9.26) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 63.12 Buy
Chaikin Money Flow: 100221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.71) Buy
Bollinger Bands (100): (0.3 - 1.84) Sell

TBPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.48 Sell
20-day SMA: 8.43 Sell
50-day SMA: 8.24 Sell
200-day SMA: 8.83 Sell
8-day EMA: 8.41 Sell
20-day EMA: 8.42 Sell
50-day EMA: 8.4 Sell
200-day EMA: 8.86 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Buy
20-day SMA: 0.64 Buy
50-day SMA: 0.6 Buy
200-day SMA: 2.66 Sell
8-day EMA: 0.69 Buy
20-day EMA: 0.66 Buy
50-day EMA: 0.74 Buy
200-day EMA: 6.3 Sell

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Theravance Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):